Sofwave Medical Reports Third Quarter 2026 Financial Results and Business Highlights
Sofwave to Participate in Upcoming November Investor Conferences
Sofwave to Participate in the Jefferies Private MedTech Virtual Summit
New Peer-Reviewed Study Shows Sustained Improvement in Skin Laxity Through Nine Months After a Single Sofwave™ Treatment in Asian Patients
Sofwave Receives NMPA Approval in Mainland China
Sofwave Announces Publication of Data from Randomized Controlled Study of its Pure Impact™ VIP Platform Utilizing PlyoPulse™ EMS Technology in Aesthetic Surgery Journal
New Peer-Reviewed Article Explores the Role of Sofwave™ and Pure Impact VIP™ in Regenerative Aesthetics
Sofwave Surpasses One Million Treatments Worldwide; Milestone Treatment Performed in South Korea
Sofwave Medical Reports Second Quarter and First Half 2026 Financial Results and Business Highlights
